KYMR – kymera therapeutics, inc. (US:NASDAQ)
Stock Stats
News
FDA Grants Fast Track Designation to Kymera Therapeutics, Inc. (KYMR)'s KT-621 for Eosinophilic Asthma [Yahoo! Finance]
Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026
Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma
Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
Does Positive KT-621 Atopic Dermatitis Data Change The Bull Case For Kymera Therapeutics (KYMR)? [Yahoo! Finance]
Form 4 Kymera Therapeutics, For: Apr 22 Filed by: Booth Bruce
Form 4 Kymera Therapeutics, For: Apr 22 Filed by: Chadwick Jeremy G
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Form 144 Kymera Therapeutics, Filed by: Chadwick Jeremy G
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.